GIANNECCHINI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.199
EU - Europa 4.325
AS - Asia 3.492
SA - Sud America 502
AF - Africa 110
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.113
RU - Federazione Russa 1.569
IT - Italia 1.012
SG - Singapore 944
CN - Cina 814
HK - Hong Kong 635
BR - Brasile 399
PL - Polonia 348
VN - Vietnam 344
IE - Irlanda 331
KR - Corea 287
SE - Svezia 231
UA - Ucraina 186
DE - Germania 169
FI - Finlandia 135
GB - Regno Unito 128
FR - Francia 126
JO - Giordania 126
IN - India 95
AU - Australia 61
CA - Canada 52
ID - Indonesia 41
BD - Bangladesh 40
JP - Giappone 40
AR - Argentina 24
ZA - Sudafrica 23
NL - Olanda 22
CI - Costa d'Avorio 21
EC - Ecuador 21
NG - Nigeria 21
TR - Turchia 21
IQ - Iraq 18
MX - Messico 18
ES - Italia 17
SC - Seychelles 14
MY - Malesia 12
UY - Uruguay 12
CO - Colombia 11
SA - Arabia Saudita 11
AT - Austria 10
VE - Venezuela 10
IR - Iran 9
PY - Paraguay 9
BE - Belgio 8
CH - Svizzera 8
CL - Cile 8
PK - Pakistan 8
PH - Filippine 7
EG - Egitto 6
MA - Marocco 6
NZ - Nuova Zelanda 6
BO - Bolivia 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KE - Kenya 5
KZ - Kazakistan 5
LK - Sri Lanka 5
KG - Kirghizistan 4
MD - Moldavia 4
TN - Tunisia 4
UZ - Uzbekistan 4
BJ - Benin 3
DK - Danimarca 3
LT - Lituania 3
PE - Perù 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
CG - Congo 2
DZ - Algeria 2
IL - Israele 2
MM - Myanmar 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.694
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.928
Ashburn 748
Singapore 711
Hong Kong 553
Fairfield 479
Warsaw 347
Dublin 331
Chandler 311
Seoul 284
Jacksonville 247
San Jose 217
Woodbridge 210
Hefei 207
Seattle 191
Houston 185
Milan 185
Cambridge 171
Beijing 167
Wilmington 157
Florence 154
Dallas 150
Lawrence 128
Altamura 127
Ho Chi Minh City 116
Los Angeles 113
The Dalles 104
Lauterbourg 102
Princeton 100
Buffalo 99
Ann Arbor 91
Hanoi 78
Moscow 71
Rome 70
Medford 61
Melbourne 58
Council Bluffs 57
Boston 51
Mumbai 50
Boardman 47
Munich 43
San Diego 40
São Paulo 38
Helsinki 37
Chicago 35
Kent 33
Shanghai 31
New York 29
Jakarta 26
London 26
Tokyo 24
Abidjan 21
Abuja 20
Lappeenranta 19
Redondo Beach 18
Toronto 18
Norwalk 17
Cardiff 16
Rio de Janeiro 16
Clifton 15
Frankfurt am Main 15
Johannesburg 15
Bologna 14
Haiphong 14
Miano 14
Naples 14
Atlanta 12
Frankfurt Am Main 12
Guangzhou 12
Hillsboro 12
Hải Dương 12
Turin 12
West Jordan 12
Chennai 11
Da Nang 11
Figino 10
Tianjin 10
Andover 9
Brooklyn 9
Guayaquil 9
Izmir 9
Orem 9
Palermo 9
San Francisco 9
Belo Horizonte 8
Bern 8
Brussels 8
Campinas 8
Dong Ket 8
Phoenix 8
Quito 8
Saint Petersburg 8
Siena 8
Turku 8
Auburn Hills 7
Bến Tre 7
Catania 7
Colombo 7
Elk Grove Village 7
Falls Church 7
Montreal 7
Totale 10.382
Salva come PNG Salva come JPEG
Nome #
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 331
Investigation of in vitro replication features of wild ducks and turkey H7N3 influenza viruses: possibile role in interspecies transmission. 263
COVID-19 Salivary Signature: Diagnostic and Research Opportunities 251
Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017 220
Extracellular vesicles engagement during respiratory viruses infection 219
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 208
Polyomavirus microRNA in saliva reveals persistent infectious status in the oral cavity 204
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein 202
Antiviral activity against SARS-CoV-2 of conformationally constrained helical peptides derived from angiotensin-converting enzyme-2. 201
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. 196
Utility of droplet digital PCR for the quantitative detection of polyomavirus JC in clinical samples 193
Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19 191
Investigation on torquetenovirus (TTV) microRNA transcriptome in vivo 190
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine. 188
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 188
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 188
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 187
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 186
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 185
BK polyomavirus microRNA levels in exosomes are modulated by non-coding control region activity, and down-regulate viral replication when delivered to non-infected cells prior to infection. 184
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 183
High-resolution melting analysis for detection of nucleotide mutation markers in the polymerase-acidic (PA) gene of influenza virus that are associated with baloxavir marboxil resistance 181
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts. 179
A retro-inverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum. 179
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies. 178
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects 178
Polyomavirus microRNAs circulating in biological fluids during viral persistence 178
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus 174
Moderate influenza vaccine effectiveness against A(H1N1)pdm09 virus, and low effectiveness against A(H3N2) subtype, 2018/19 season in Italy 166
The Emergence of Saliva as a Diagnostic and Prognostic Tool for Viral Infections 165
AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus. 164
DDX3X helicase inhibitors as new strategy to fight West Nile Virus infection. 163
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env 162
Detection of Polyomavirus microRNA-5p Expression in Saliva Short-Term after Kidney Transplantation 161
Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein 159
West Nile virus seroprevalence in the Italian Tuscany region from 2016 to 2019 159
Quantification of torque teno virus (TTV) DNA in saliva and plasma samples in patients at short time before and after kidney transplantation 159
Antiviral activity of oligonucleotides targeting the SARS-CoV-2 genomic RNA stem-loop sequences within the 3’-end of the ORF1b. 159
Synthesis, conformational analysis and biological activity evaluation of novel antiviral peptides blocking the SARS-CoV-2 cell-entry 158
Multiple signatures of the JC polyomavirus in paired normal and altered colorectal mucosa indicate a link with human colorectal cancer, but not with cancer progression. 158
Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. 157
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19 157
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples. 156
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine. 155
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 149
Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy 146
Oligonucleotides derived from the packaging signal at the 5’ end of the viral PB2 segment specifically inhibit influenza virus in vitro 146
High Resolution Melting (HRM) analysis for rapid risk assessment of reassortment of avian H5N1 influenza virus with circulating human influenza virus 145
Are there lessons that can be learned from the FIV model ? 145
Polyomavirus JC microRNAs expression after infection in vitro. 143
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors. 143
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 142
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity 141
The inhibition of a plant proteinase by lysine copolymers is modulated by the hydrophobicity of interposed amino acid side chains. 141
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 141
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples. 141
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein. 141
Dissection of seroreactivity against the tryptophan-rich motif of feline immunodeficiency virus transmembrane glycoprotein. 140
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats. 140
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 139
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. 138
Screening of the essential oil effects on human H1N1 influenza virus infection: an in vitro study in MDCK cells 135
Feline immunodeficiency virus-infected cat sera associated with the development of broad neutralization resistance in vivo drive similar reversions in vitro. 134
Investigation of Oral Shedding of Torquetenovirus (TTV) in Moderate-to-Severe COVID-19 Hospitalised Patients 132
INCUBATION TIME FOR FELINE IMMUNODEFICIENCY VIRUS CULTURES. 132
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. 132
A retroinverso peptide reproducing the Trp-rich motif of the FIV TM has favorable pharmacological traits and markedly reduces viral loads in a short-monotherapy experiment. 132
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 130
Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats. 127
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 127
Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the Feline Immunodeficiency Virus and its lipoylated analogue in micellar systems. 127
Torque teno virus microRNA detection in cerebrospinal fluids of patients with neurological pathologies 124
Evolution of two amino acid positions governing broad neutralization resistence in a strain of feline immunodeficiency virus over 7 years of persistence in cats. 121
Role of Env in the resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV, as determined using a chimeric virus 121
Pancreas rejection after pandemic influenzavirus A(H1N1)vaccination or infection: a report of two cases 121
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 120
In vitro selection of a human H1N1 influenza virus with zanamivir in presence of sialic acid-containing molecules changes its susceptibility to this inhibitor through substitutions in the neuraminidase and hemagglutinin. 119
In vitro and ex vivo detection of human polyomavirus JC microRNA 119
Factors associated with death due to severe acute respiratory syndrome caused by influenza: Brazilian population study. 118
Severe acute respiratory syndrome by influenza and factors associated with death in older adults: a population study: Factors associated with death due to influenza 116
Evidence of the mechanism by which polyomaviruses exploit the extracellular vesicle delivery system during infection 116
SARS-CoV-2: What Can Saliva Tell Us? 115
Antibodies generated in cats by a lipopeptide reproducing the MPER of the feline immunodeficiency virus TM enhance virus infectivity 113
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 113
Single-round virus replication assay for assisting the design of small molecules inhibiting HIV entry in host cells. 110
Lack of direct association between oral mucosal lesions and SARS-CoV- 2 in a cohort of patients hospitalised with COVID-19 110
MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19 110
Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in V4 region of the surface glycoprotein. 109
Sudies on AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted. 108
Volatiles and Antifungal-Antibacterial-Antiviral Activity of South African Salvia spp. Essential Oils Cultivated in Uniform Conditions 106
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizating antibodies. 106
Effect of enzymatic deglycosylation on feline immunodeficiency virus sensitivity to antibody-mediated neutralization. 105
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 105
Selezione in vitro di varianti virali di virus dell’ influenza aviaria H7N3 dell’anatra in presenza di sialogangliosidi. 102
Development of new antivirals against the influenza type A viruses based on small RNAs targeting the packaging signal of the polymarases gene coding region. 98
Erratum: Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: A report of two cases (Transplant International (2011) 24 (e28)) 95
New influenza virus type A (H1N1), isolated in Florence. 93
Investigation of reassortment ability of pandemic H1N1 influenza virus with circulating human and avian influenza viruses. 93
Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection 91
Polyomavirus JC detection in patients with rheumatic disease after a long-term treatment with infliximab. 90
Totale 15.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.937
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022626 13 57 65 14 25 20 27 25 22 37 126 195
2022/20231.602 154 318 53 91 120 272 202 62 234 17 53 26
2023/2024583 26 87 116 38 39 34 31 110 14 41 32 15
2024/20254.957 136 491 299 581 1.174 1.133 87 427 144 140 174 171
2025/20265.152 502 809 481 416 590 186 635 271 318 247 136 561
2026/202732 32 0 0 0 0 0 0 0 0 0 0 0
Totale 15.909